aluates Reports

$ 0.0

Automative

Global Immuno-oncology Clinical Trials Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-17E6476

Global Immuno oncology Clinical Trials Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Immuno-oncology Clinical Trials Market Research Report 2025

Code: QYRE-Auto-17E6476

Report

September 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medpace

Novartis

Exscientia Ltd

Syneous Health

Astrazeneca plc

ICON

IQVIA Holdings

BioNTech

Covance

IO BIOTECH

Immuno-oncology Clinical Trials Market

The global market for Immuno-oncology Clinical Trials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.

North American market for Immuno-oncology Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Immuno-oncology Clinical Trials is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Immuno-oncology Clinical Trials in Solid Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Immuno-oncology Clinical Trials include Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech, Covance, Inc., IO BIOTECH, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immuno-oncology Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-oncology Clinical Trials.

The Immuno-oncology Clinical Trials market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immuno-oncology Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immuno-oncology Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immuno-oncology Clinical Trials Market Report

Report Metric	Details
Report Name	Immuno-oncology Clinical Trials Market
Segment by Type	Phase I Phase II Phase III Phase IV
Segment by Application	Solid Tumors Hematological Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech, Covance, Inc., IO BIOTECH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-oncology Clinical Trials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Immuno-oncology Clinical Trials Market report?

Ans: The main players in the Immuno-oncology Clinical Trials Market are Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech, Covance, Inc., IO BIOTECH

What are the Application segmentation covered in the Immuno-oncology Clinical Trials Market report?

Ans: The Applications covered in the Immuno-oncology Clinical Trials Market report are Solid Tumors, Hematological Cancer

What are the Type segmentation covered in the Immuno-oncology Clinical Trials Market report?

Ans: The Types covered in the Immuno-oncology Clinical Trials Market report are Phase I, Phase II, Phase III, Phase IV

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immuno-oncology Clinical Trials Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Phase I

1.2.3 Phase II

1.2.4 Phase III

1.2.5 Phase IV

1.3 Market by Application

1.3.1 Global Immuno-oncology Clinical Trials Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Tumors

1.3.3 Hematological Cancer

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immuno-oncology Clinical Trials Market Perspective (2020-2031)

2.2 Global Immuno-oncology Clinical Trials Growth Trends by Region

2.2.1 Global Immuno-oncology Clinical Trials Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Immuno-oncology Clinical Trials Historic Market Size by Region (2020-2025)

2.2.3 Immuno-oncology Clinical Trials Forecasted Market Size by Region (2026-2031)

2.3 Immuno-oncology Clinical Trials Market Dynamics

2.3.1 Immuno-oncology Clinical Trials Industry Trends

2.3.2 Immuno-oncology Clinical Trials Market Drivers

2.3.3 Immuno-oncology Clinical Trials Market Challenges

2.3.4 Immuno-oncology Clinical Trials Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immuno-oncology Clinical Trials Players by Revenue

3.1.1 Global Top Immuno-oncology Clinical Trials Players by Revenue (2020-2025)

3.1.2 Global Immuno-oncology Clinical Trials Revenue Market Share by Players (2020-2025)

3.2 Global Immuno-oncology Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Immuno-oncology Clinical Trials Revenue

3.4 Global Immuno-oncology Clinical Trials Market Concentration Ratio

3.4.1 Global Immuno-oncology Clinical Trials Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immuno-oncology Clinical Trials Revenue in 2024

3.5 Global Key Players of Immuno-oncology Clinical Trials Head office and Area Served

3.6 Global Key Players of Immuno-oncology Clinical Trials, Product and Application

3.7 Global Key Players of Immuno-oncology Clinical Trials, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-oncology Clinical Trials Breakdown Data by Type

4.1 Global Immuno-oncology Clinical Trials Historic Market Size by Type (2020-2025)

4.2 Global Immuno-oncology Clinical Trials Forecasted Market Size by Type (2026-2031)

5 Immuno-oncology Clinical Trials Breakdown Data by Application

5.1 Global Immuno-oncology Clinical Trials Historic Market Size by Application (2020-2025)

5.2 Global Immuno-oncology Clinical Trials Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Immuno-oncology Clinical Trials Market Size (2020-2031)

6.2 North America Immuno-oncology Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Immuno-oncology Clinical Trials Market Size by Country (2020-2025)

6.4 North America Immuno-oncology Clinical Trials Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immuno-oncology Clinical Trials Market Size (2020-2031)

7.2 Europe Immuno-oncology Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Immuno-oncology Clinical Trials Market Size by Country (2020-2025)

7.4 Europe Immuno-oncology Clinical Trials Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immuno-oncology Clinical Trials Market Size (2020-2031)

8.2 Asia-Pacific Immuno-oncology Clinical Trials Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Immuno-oncology Clinical Trials Market Size by Region (2020-2025)

8.4 Asia-Pacific Immuno-oncology Clinical Trials Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immuno-oncology Clinical Trials Market Size (2020-2031)

9.2 Latin America Immuno-oncology Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Immuno-oncology Clinical Trials Market Size by Country (2020-2025)

9.4 Latin America Immuno-oncology Clinical Trials Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immuno-oncology Clinical Trials Market Size (2020-2031)

10.2 Middle East & Africa Immuno-oncology Clinical Trials Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Immuno-oncology Clinical Trials Market Size by Country (2020-2025)

10.4 Middle East & Africa Immuno-oncology Clinical Trials Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medpace

11.1.1 Medpace Company Details

11.1.2 Medpace Business Overview

11.1.3 Medpace Immuno-oncology Clinical Trials Introduction

11.1.4 Medpace Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.1.5 Medpace Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Immuno-oncology Clinical Trials Introduction

11.2.4 Novartis Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Exscientia

11.3.1 Exscientia Company Details

11.3.2 Exscientia Business Overview

11.3.3 Exscientia Immuno-oncology Clinical Trials Introduction

11.3.4 Exscientia Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.3.5 Exscientia Recent Development

11.4 Syneous Health

11.4.1 Syneous Health Company Details

11.4.2 Syneous Health Business Overview

11.4.3 Syneous Health Immuno-oncology Clinical Trials Introduction

11.4.4 Syneous Health Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.4.5 Syneous Health Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Immuno-oncology Clinical Trials Introduction

11.5.4 AstraZeneca Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 ICON plc

11.6.1 ICON plc Company Details

11.6.2 ICON plc Business Overview

11.6.3 ICON plc Immuno-oncology Clinical Trials Introduction

11.6.4 ICON plc Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.6.5 ICON plc Recent Development

11.7 IQVIA Holdings

11.7.1 IQVIA Holdings Company Details

11.7.2 IQVIA Holdings Business Overview

11.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Introduction

11.7.4 IQVIA Holdings Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.7.5 IQVIA Holdings Recent Development

11.8 BioNtech

11.8.1 BioNtech Company Details

11.8.2 BioNtech Business Overview

11.8.3 BioNtech Immuno-oncology Clinical Trials Introduction

11.8.4 BioNtech Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.8.5 BioNtech Recent Development

11.9 Covance, Inc.

11.9.1 Covance, Inc. Company Details

11.9.2 Covance, Inc. Business Overview

11.9.3 Covance, Inc. Immuno-oncology Clinical Trials Introduction

11.9.4 Covance, Inc. Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.9.5 Covance, Inc. Recent Development

11.10 IO BIOTECH

11.10.1 IO BIOTECH Company Details

11.10.2 IO BIOTECH Business Overview

11.10.3 IO BIOTECH Immuno-oncology Clinical Trials Introduction

11.10.4 IO BIOTECH Revenue in Immuno-oncology Clinical Trials Business (2020-2025)

11.10.5 IO BIOTECH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medpace

Novartis

Exscientia Ltd

Syneous Health

Astrazeneca plc

ICON

IQVIA Holdings

BioNTech

Covance

IO BIOTECH

List of Tables

Table 1. Global Immuno-oncology Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Phase I

Table 3. Key Players of Phase II

Table 4. Key Players of Phase III

Table 5. Key Players of Phase IV

Table 6. Global Immuno-oncology Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Immuno-oncology Clinical Trials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Immuno-oncology Clinical Trials Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Immuno-oncology Clinical Trials Market Share by Region (2020-2025)

Table 10. Global Immuno-oncology Clinical Trials Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Immuno-oncology Clinical Trials Market Share by Region (2026-2031)

Table 12. Immuno-oncology Clinical Trials Market Trends

Table 13. Immuno-oncology Clinical Trials Market Drivers

Table 14. Immuno-oncology Clinical Trials Market Challenges

Table 15. Immuno-oncology Clinical Trials Market Restraints

Table 16. Global Immuno-oncology Clinical Trials Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Immuno-oncology Clinical Trials Market Share by Players (2020-2025)

Table 18. Global Top Immuno-oncology Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Clinical Trials as of 2024)

Table 19. Ranking of Global Top Immuno-oncology Clinical Trials Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Immuno-oncology Clinical Trials Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Immuno-oncology Clinical Trials, Headquarters and Area Served

Table 22. Global Key Players of Immuno-oncology Clinical Trials, Product and Application

Table 23. Global Key Players of Immuno-oncology Clinical Trials, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Immuno-oncology Clinical Trials Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Immuno-oncology Clinical Trials Revenue Market Share by Type (2020-2025)

Table 27. Global Immuno-oncology Clinical Trials Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Immuno-oncology Clinical Trials Revenue Market Share by Type (2026-2031)

Table 29. Global Immuno-oncology Clinical Trials Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Immuno-oncology Clinical Trials Revenue Market Share by Application (2020-2025)

Table 31. Global Immuno-oncology Clinical Trials Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Immuno-oncology Clinical Trials Revenue Market Share by Application (2026-2031)

Table 33. North America Immuno-oncology Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Immuno-oncology Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Immuno-oncology Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Immuno-oncology Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Immuno-oncology Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Immuno-oncology Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Immuno-oncology Clinical Trials Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Immuno-oncology Clinical Trials Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Immuno-oncology Clinical Trials Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Immuno-oncology Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Immuno-oncology Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Immuno-oncology Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Immuno-oncology Clinical Trials Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Immuno-oncology Clinical Trials Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Immuno-oncology Clinical Trials Market Size by Country (2026-2031) & (US$ Million)

Table 48. Medpace Company Details

Table 49. Medpace Business Overview

Table 50. Medpace Immuno-oncology Clinical Trials Product

Table 51. Medpace Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 52. Medpace Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Immuno-oncology Clinical Trials Product

Table 56. Novartis Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Exscientia Company Details

Table 59. Exscientia Business Overview

Table 60. Exscientia Immuno-oncology Clinical Trials Product

Table 61. Exscientia Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 62. Exscientia Recent Development

Table 63. Syneous Health Company Details

Table 64. Syneous Health Business Overview

Table 65. Syneous Health Immuno-oncology Clinical Trials Product

Table 66. Syneous Health Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 67. Syneous Health Recent Development

Table 68. AstraZeneca Company Details

Table 69. AstraZeneca Business Overview

Table 70. AstraZeneca Immuno-oncology Clinical Trials Product

Table 71. AstraZeneca Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 72. AstraZeneca Recent Development

Table 73. ICON plc Company Details

Table 74. ICON plc Business Overview

Table 75. ICON plc Immuno-oncology Clinical Trials Product

Table 76. ICON plc Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 77. ICON plc Recent Development

Table 78. IQVIA Holdings Company Details

Table 79. IQVIA Holdings Business Overview

Table 80. IQVIA Holdings Immuno-oncology Clinical Trials Product

Table 81. IQVIA Holdings Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 82. IQVIA Holdings Recent Development

Table 83. BioNtech Company Details

Table 84. BioNtech Business Overview

Table 85. BioNtech Immuno-oncology Clinical Trials Product

Table 86. BioNtech Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 87. BioNtech Recent Development

Table 88. Covance, Inc. Company Details

Table 89. Covance, Inc. Business Overview

Table 90. Covance, Inc. Immuno-oncology Clinical Trials Product

Table 91. Covance, Inc. Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 92. Covance, Inc. Recent Development

Table 93. IO BIOTECH Company Details

Table 94. IO BIOTECH Business Overview

Table 95. IO BIOTECH Immuno-oncology Clinical Trials Product

Table 96. IO BIOTECH Revenue in Immuno-oncology Clinical Trials Business (2020-2025) & (US$ Million)

Table 97. IO BIOTECH Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Immuno-oncology Clinical Trials Picture

Figure 2. Global Immuno-oncology Clinical Trials Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Immuno-oncology Clinical Trials Market Share by Type: 2024 VS 2031

Figure 4. Phase I Features

Figure 5. Phase II Features

Figure 6. Phase III Features

Figure 7. Phase IV Features

Figure 8. Global Immuno-oncology Clinical Trials Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Immuno-oncology Clinical Trials Market Share by Application: 2024 VS 2031

Figure 10. Solid Tumors Case Studies

Figure 11. Hematological Cancer Case Studies

Figure 12. Immuno-oncology Clinical Trials Report Years Considered

Figure 13. Global Immuno-oncology Clinical Trials Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Immuno-oncology Clinical Trials Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Immuno-oncology Clinical Trials Market Share by Region: 2024 VS 2031

Figure 16. Global Immuno-oncology Clinical Trials Market Share by Players in 2024

Figure 17. Global Top Immuno-oncology Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Clinical Trials as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Immuno-oncology Clinical Trials Revenue in 2024

Figure 19. North America Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Immuno-oncology Clinical Trials Market Share by Country (2020-2031)

Figure 21. United States Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Immuno-oncology Clinical Trials Market Share by Country (2020-2031)

Figure 25. Germany Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Immuno-oncology Clinical Trials Market Share by Region (2020-2031)

Figure 33. China Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Immuno-oncology Clinical Trials Market Share by Country (2020-2031)

Figure 41. Mexico Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Immuno-oncology Clinical Trials Market Share by Country (2020-2031)

Figure 45. Turkey Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Immuno-oncology Clinical Trials Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Medpace Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 50. Exscientia Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 51. Syneous Health Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 53. ICON plc Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 54. IQVIA Holdings Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 55. BioNtech Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 56. Covance, Inc. Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 57. IO BIOTECH Revenue Growth Rate in Immuno-oncology Clinical Trials Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immuno Oncology Service Market Research Report 2024

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Oncology Clinical Trial Market Research Report 2024

Global Drug Delivery Technology Market Research Report 2024

Immuno oncology Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Global Antibodies in Oncology Market Research Report 2024

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Global Immuno Oncology Assays Kit Market Insights Forecast to 2030

Oncology Immuno Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology and Cancer Treatment Drug Market Research Report 2024

Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030

Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Oncology Diagnostics Market Research Report 2024

Immuno Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti PD 1 MAb Market Insights Forecast to 2030

Oncology Immunotherapy Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions